Saghar Barati

423 total citations
25 papers, 312 citations indexed

About

Saghar Barati is a scholar working on Infectious Diseases, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Saghar Barati has authored 25 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 6 papers in Neurology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Saghar Barati's work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (8 papers) and Long-Term Effects of COVID-19 (6 papers). Saghar Barati is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (8 papers) and Long-Term Effects of COVID-19 (6 papers). Saghar Barati collaborates with scholars based in Iran, United States and India. Saghar Barati's co-authors include Farzaneh Dastan, Payam Tabarsi, Nikolai Petrovsky, Majid Marjani, Sara Haseli, Hamidreza Jamaati, Masoud Mardani, Mitra Rezaei, Raha Eskandari and Atefeh Fakharian and has published in prestigious journals such as Scientific Reports, Clinical Microbiology and Infection and Frontiers in Pharmacology.

In The Last Decade

Saghar Barati

24 papers receiving 306 citations

Peers

Saghar Barati

NEURO

IMMUN

HEALT

Andreas Zollner Austria

Joo-Yeon Lee South Korea

Yasutaka Fukui Japan

Tracey Freeman United States

Sophia J. Kiechl Austria

Greg Nigh United States

Maheswari Kulandhasamy India

Xiaojia Tang China

W. X. Gong China

Andreas Zollner Austria

Saghar Barati

185 ×0.9

87 ×1.4

144 ×2.8

NEURO

39 ×0.9

IMMUN

8 ×0.2

HEALT

Citations per year, relative to Saghar Barati Saghar Barati (= 1×) peers Andreas Zollner

Countries citing papers authored by Saghar Barati

Since Specialization

Citations

This map shows the geographic impact of Saghar Barati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saghar Barati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saghar Barati more than expected).

Fields of papers citing papers by Saghar Barati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saghar Barati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saghar Barati. The network helps show where Saghar Barati may publish in the future.

Co-authorship network of co-authors of Saghar Barati

This figure shows the co-authorship network connecting the top 25 collaborators of Saghar Barati. A scholar is included among the top collaborators of Saghar Barati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saghar Barati. Saghar Barati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Petrovsky, Nikolai, et al.. (2024). Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis. Scientific Reports. 14(1). 22631–22631. 3 indexed citations

Honda‐Okubo, Yoshikazu, et al.. (2023). Ability of SpikoGen®, an Advax‐CpG adjuvanted recombinant spike protein vaccine, to induce cross‐neutralising antibodies against SARS‐CoV‐2 variants. Immunology. 170(2). 193–201. 11 indexed citations

Tabarsi, Payam, et al.. (2023). Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: An immuno-bridging clinical trial. International Immunopharmacology. 127. 111436–111436. 6 indexed citations

Dastan, Farzaneh, Saghar Barati, & Zargham Hossein Ahmadi. (2023). Evaluating the Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation following Coronary Artery Bypass Graft Surgery: A Randomised Controlled Trial. European Cardiology Review. 18. e25–e25. 1 indexed citations

Dastan, Farzaneh, et al.. (2023). The effects of combination-therapy of tocilizumab and baricitinib on the management of severe COVID-19 cases: a randomized open-label clinical trial. Frontiers in Pharmacology. 14. 1265541–1265541. 3 indexed citations

Barati, Saghar, et al.. (2022). Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial. Revista Portuguesa de Cardiologia. 42(2). 139–144. 8 indexed citations

Tabarsi, Payam, et al.. (2022). Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS‐CoV‐2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo‐controlled trial. Immunology. 167(3). 340–353. 33 indexed citations

Tabarsi, Payam, et al.. (2022). Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-controlled trial. Clinical Microbiology and Infection. 29(2). 215–220. 36 indexed citations

Nafar, Mohsen, A. Firouzan, Fariba Samadian, et al.. (2022). Immunogenicity and Safety of SpikoGen, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein, as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-arm Clinical Trial. Clinical Therapeutics. 44(12). 1566–1576. 4 indexed citations

10.

Tabarsi, Payam, et al.. (2022). Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations. Clinical Microbiology and Infection. 28(9). 1263–1271. 43 indexed citations

11.

Shabani, Minoosh, Mohammadreza Hajiesmaeili, Maria Tavakoli‐Ardakani, et al.. (2021). The effects of vitamin E on colistin-induced nephrotoxicity in treatment of drug-resistant gram-negative bacterial infections: A randomized clinical trial. Journal of Infection and Chemotherapy. 27(8). 1181–1185. 6 indexed citations

12.

Dastan, Farzaneh, et al.. (2021). Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis. Canadian Journal of Infectious Diseases and Medical Microbiology. 2021. 1–6. 10 indexed citations

13.

Barati, Saghar, et al.. (2021). Assessing multiple sclerosis-related quality of life among Iranian patients using the MSQOL-54 tool: a cross-sectional study. BMC Neurology. 21(1). 333–333. 4 indexed citations

14.

Fakharian, Atefeh, Saghar Barati, Mitra Rezaei, et al.. (2021). Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial. International Immunopharmacology. 99. 107961–107961. 27 indexed citations

15.

Shokouhi, Shervin, et al.. (2021). Evaluating the elimination status of medications used for COVID-19 during hemoperfusion and therapeutic plasma exchange: A review. International Immunopharmacology. 97. 107707–107707. 7 indexed citations

16.

Fakharian, Atefeh, et al.. (2021). Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient. Journal of Cardiothoracic and Vascular Anesthesia. 36(4). 1115–1117. 9 indexed citations

17.

Barati, Saghar, Seyed Mohammad Reza Hashemian, Payam Tabarsi, et al.. (2021). Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial. International Immunopharmacology. 99. 108043–108043. 1 indexed citations

18.

Barati, Saghar, et al.. (2020). The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial. Endocrine Metabolic & Immune Disorders - Drug Targets. 21(6). 1142–1149. 14 indexed citations

19.

Tabarsi, Payam, Saghar Barati, Hamidreza Jamaati, et al.. (2020). Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. International Immunopharmacology. 90. 107205–107205. 55 indexed citations

20.

Barati, Saghar, et al.. (2016). A role for ATP-sensitive potassium channels in the anticonvulsant effects of triamterene in mice. Epilepsy Research. 121. 8–13. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact